| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493451A1 Hemostatic devices and methods of making same |
| 01/05/2005 | EP1492883A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 01/05/2005 | EP1492821A1 Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 01/05/2005 | EP1492789A1 Tropane derivatives as ccr5 modulators |
| 01/05/2005 | EP1492779A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 01/05/2005 | EP1492767A1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
| 01/05/2005 | EP1492761A2 Amino acids with affinity for the alpha-2-delta-protein |
| 01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
| 01/05/2005 | EP1492552A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 01/05/2005 | EP1492549A1 Compositions and methods for augmenting kidney function |
| 01/05/2005 | EP1492501A1 Methods of using lamellar bodies for therapeutic purposes |
| 01/05/2005 | EP1248630B9 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 01/05/2005 | EP1226126B1 Pyrimidine derivatives |
| 01/05/2005 | EP1109537B1 Immediate release oral formulation comprising peptide thrombin inhibitors and a combination of microcrystalline cellulose and sodium starch glycollate |
| 01/05/2005 | EP1027051B1 Antithrombotic agents |
| 01/05/2005 | EP1015449B1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors |
| 01/05/2005 | DE10327428A1 Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor Xa inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then aniline derivative |
| 01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1561231A Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 01/05/2005 | CN1561226A Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1561208A Methods to mobilize progenitor/stem cells |
| 01/05/2005 | CN1561207A Therapeutic delivery of carbon monoxide |
| 01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560241A Mutant of recombined glucokinase for anti blood platelet collecting and low immunogencity |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/05/2005 | CN1559597A Disinfectant |
| 01/05/2005 | CN1559571A Jiangjie blood supplementing mixture and its application |
| 01/05/2005 | CN1559550A New type medicina preparation with one chinese medicinal herb extract ant its preparation method |
| 01/05/2005 | CN1559474A Chinese medicinal preparation of anti embolus disease and its preparation method |
| 01/05/2005 | CN1559469A Prepn. method for freezing-drying powder injection for treating cardiovascular disease |
| 01/05/2005 | CN1559446A Antimicrobial (tincture)medicine with functons of analgesia, hemostasis and relieving-itching |
| 01/05/2005 | CN1559445A Antimicrobial (aqua)medicine with functions of analgesia, hemostasis and reliveing-itching |
| 01/05/2005 | CN1559443A Sturgeon chondroition capsule and instant granula prepn. method therefor |
| 01/05/2005 | CN1559412A Freezing-drying powder-injection contg. sodium folinate, and its prepn. method |
| 01/05/2005 | CN1559391A Volume-expansion protection agent, and application in treating blood-loss shock |
| 01/05/2005 | CN1559387A Intravenous injection liquid of coenzyme Q10, and its prepn. method |
| 01/05/2005 | CN1559386A Method for preparing emodin liquid |
| 01/05/2005 | CN1183160C Human anti-factor IX/IXa antibodies |
| 01/05/2005 | CN1183134C Tricyclic vasporessin agonists |
| 01/05/2005 | CN1183129C Condensed azepines as vasporession agonists |
| 01/05/2005 | CN1183128C N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants |
| 01/05/2005 | CN1182844C Use of dialkylfumarates |
| 01/04/2005 | US6838479 Amidine inhibitors of serine proteases |
| 01/04/2005 | US6838478 Use as anticoagulants; competitive inhibitors of thrombin; for example, 1-(phenyl-2-hydroxyethane-1,1-diylcarbonyl), 2-((4-amidinophenyl)-alkylaminocarbonyl)azetidine |
| 01/04/2005 | US6838460 Substituted phenylamidines medicaments containing said compounds and method for production thereof |
| 01/04/2005 | US6838459 7-alkyl-and cycloalkyl-substituted imidazotriazinones |
| 01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 01/04/2005 | US6838437 Inactivation resistant factor VIII |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838096 Black soybean polysaccharides |
| 01/04/2005 | CA2350854C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/04/2005 | CA2288341C Erythropoietin in the treatment of domestic and livestock animals for anemia |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/30/2004 | US20040266864 Possess potent serotonin reuptake inhibitory activity, with minimal inhibitory effects on the reuptake of other known monoamines, e.g., norepinephrine or dopamine; also useful for treating or preventing other CNS disorders, cerebrovascular or vascular dysfunctions, sexual dysfunctiions, eating disorders |
| 12/30/2004 | US20040266841 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 12/30/2004 | US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 12/30/2004 | US20040266775 for human, veterinary, or phytoprotective use, e.g., inhibiting the cellular sodium-proton antiporter activity, for the treatment of cardiovascular diseases, metabolic diseases, cancerous diseases or fibrotic diseases |
| 12/30/2004 | US20040266759 Possess antithrombotic and anticoagulant properties; example compound: 1-(5-Chlorobenzo[b]furan-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl]piperazine |
| 12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
| 12/30/2004 | US20040266733 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1) |
| 12/30/2004 | US20040266694 Angiogenesis inhibitor induced by vascular endothelial growth factor |
| 12/30/2004 | US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/30/2004 | US20040265981 A cDna clone; culturing liver cell in coditioning media |
| 12/30/2004 | US20040265971 Cytokine for use in stem cell propagation and treatment ot cardiovascular, bone, nervous system and inflammatory disorders |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265371 Hemostatic devices and methods of making same |
| 12/30/2004 | US20040265311 Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity |
| 12/30/2004 | US20040265284 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
| 12/29/2004 | WO2004113363A2 Dipeptide transglutaminase inhibitors and methods of using the same |
| 12/29/2004 | WO2004113316A1 Benzofuran inhibitors of factor viia |
| 12/29/2004 | WO2004113278A2 Acylsulfamide inhibitors of factor viia |
| 12/29/2004 | WO2004089964A8 Lipid-regulating agent and use thereof |
| 12/29/2004 | WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | WO2000061774A3 Bone morphogenic proteins |
| 12/29/2004 | EP1491541A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491540A1 Pyridazinone aldose reductase inhibitors |
| 12/29/2004 | EP1491524A2 Selective androgen receptor modulators and methods of use thereof |
| 12/29/2004 | EP1491194A1 Vdac regulator |
| 12/29/2004 | EP1491193A1 Therapeutic combinations comprising amlodipine and atorvastatin |
| 12/29/2004 | EP1491192A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon |
| 12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/29/2004 | EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 12/29/2004 | EP1490483A2 In vivo incorporation of unnatural amino acids |
| 12/29/2004 | EP1490406A1 Costimulatory molecule and its use |
| 12/29/2004 | EP1490386A2 Novel polypeptides and nucleic acids encoding the same |
| 12/29/2004 | EP1490365A1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 12/29/2004 | EP1490364A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 12/29/2004 | EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 12/29/2004 | EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |